EMA Authorised: Livogiva (teriparatide) — Theramex Ireland Limited

View source ↗

Summary

The European Medicines Agency has authorised Livogiva, a teriparatide product by Theramex Ireland Limited, for the treatment of osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Livogiva (teriparatide)

Snippet

Status: Authorised. Therapeutic area: Osteoporosis. MAH: Theramex Ireland Limited. Decision date: 14/04/2025